User profiles for Ludhmila Abrahão Hajjar
 | Ludhmila Abrahao HajjarFaculdade de Medicina da Universidade de São Paulo Verified email at usp.br Cited by 15304 |
Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS …
…, D Baía-da-Silva, MVF Guerra, LA Hajjar… - JAMA network …, 2020 - jamanetwork.com
Importance There is no specific antiviral therapy recommended for coronavirus disease 2019
(COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ…
(COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ…
Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial
…, MH Higuchi-dos-Santos, LA Hajjar… - Journal of the American …, 2018 - jacc.org
Background : Anthracycline (ANT) chemotherapy is associated with cardiotoxicity. Prevention
with β-blockers remains controversial. Objectives : This prospective, randomized, double-…
with β-blockers remains controversial. Objectives : This prospective, randomized, double-…
Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb …
…, GA Pivoto João, LA Hajjar… - Clinical Infectious …, 2021 - academic.oup.com
Background Steroid use for coronavirus disease 2019 (COVID-19) is based on the possible
role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by …
role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by …
Worldwide survey of COVID-19–associated arrhythmias
…, M Scanavacca, L Abrahão Hajjar… - Circulation …, 2021 - Am Heart Assoc
Background: Coronavirus disease 2019 (COVID-19) has led to over 1 million deaths worldwide
and has been associated with cardiac complications including cardiac arrhythmias. The …
and has been associated with cardiac complications including cardiac arrhythmias. The …
Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial
…, M Brito, MPG Mourão, GA Pivoto-João, LA Hajjar… - 2020 - arca.fiocruz.br
Background: Steroid use for COVID-19 is based on the possible role of these drugs in
mitigating the inflammatory response, mainly in the lungs, triggered by SARS-CoV-2. This study …
mitigating the inflammatory response, mainly in the lungs, triggered by SARS-CoV-2. This study …
The burden of uncontrolled cardiovascular risk factors in men with prostate cancer: a RADICAL-PC analysis
Background Cardiovascular disease (CVD) incidence is higher in men with prostate cancer (PC)
than without. Objectives We describe the rate and correlates of poor cardiovascular risk …
than without. Objectives We describe the rate and correlates of poor cardiovascular risk …
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS …
…, D Baía-da-Silva, MV Farias Guerra, L Abrahão Hajjar… - MedRxiv, 2020 - medrxiv.org
Background There is no specific antiviral therapy recommended for the disease caused by
SARS-CoV-2 (COVID-19). Recent publications have drawn attention to the possible benefit of …
SARS-CoV-2 (COVID-19). Recent publications have drawn attention to the possible benefit of …
Intensive care management of patients with COVID-19: a practical approach
SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), is responsible
for the largest pandemic facing humanity since the Spanish flu pandemic in the early …
for the largest pandemic facing humanity since the Spanish flu pandemic in the early …
[HTML][HTML] The heart and COVID-19: what cardiologists need to know
…, JAF Ramires, R Kalil Filho, LA Hajjar - Arquivos brasileiros de …, 2020 - SciELO Brasil
Frente à pandemia da doença causada pelo novo coronavírus (COVID-19), o manejo do
paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As …
paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As …
Corticosteroids for patients with coronavirus disease 2019 (COVID-19) with different disease severity: a meta-analysis of randomized clinical trials
…, A Kuzovlev, V Likhvantsev, LA Hajjar… - Journal of cardiothoracic …, 2021 - Elsevier
Objectives Efficacy and safety of corticosteroids in patients with 2019-nCoV (novel coronavirus
2019) infection still are debated. Because large randomized clinical trials (RCTs) and a …
2019) infection still are debated. Because large randomized clinical trials (RCTs) and a …
